Sure, your text describes detailed methodologies related primarily focusing upon mechanisms controlling inflammatory processes. While highlighting novel insights gained through overexpression assays involving downstream signaling pathways triggered via phosphorylation events leading ultimately impacting immune system dynamics within cancerous lesions